SignatureFD’s Quest Diagnostics DGX Stock Holding History

SignatureFD’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$333K	Buy	1,699 +61	+4%	+$11.9K	0.01%	764
2025 Q4	$284K	Sell	1,638 -6	-0.4%	-$1.09K	﹤0.01%	809
2025 Q3	$313K	Sell	1,644 -130	-7%	-$23.1K	﹤0.01%	757
2025 Q2	$319K	Buy	1,774 +118	+7%	+$20.5K	0.01%	708
2025 Q1	$280K	Sell	1,656 -89	-5%	-$14.6K	0.01%	737
2024 Q4	$263K	Buy	1,745 +222	+15%	+$34.5K	0.01%	753
2024 Q3	$236K	Sell	1,523 -50	-3%	-$7.47K	﹤0.01%	785
2024 Q2	$215K	Buy	1,573 +235	+18%	+$32.2K	﹤0.01%	788
2024 Q1	$178K	Sell	1,338 -36	-3%	-$4.67K	﹤0.01%	876
2023 Q4	$189K	Buy	1,374 +418	+44%	+$55K	﹤0.01%	815
2023 Q3	$116K	Sell	956 -504	-35%	-$67.2K	﹤0.01%	978
2023 Q2	$205K	Buy	1,460 +433	+42%	+$59.7K	0.01%	748
2023 Q1	$145K	Sell	1,027 -147	-13%	-$21K	﹤0.01%	855
2022 Q4	$184K	Buy	1,174 +43	+4%	+$6.18K	0.01%	738
2022 Q3	$139K	Sell	1,131 -58	-5%	-$7.64K	﹤0.01%	807
2022 Q2	$158K	Buy	1,189 +89	+8%	+$12.1K	0.01%	778
2022 Q1	$151K	Buy	1,100 +36	+3%	+$5.02K	﹤0.01%	839
2021 Q4	$184K	Buy	1,064 +74	+7%	+$11.3K	0.01%	753
2021 Q3	$144K	Buy	990 +103	+12%	+$15.1K	0.01%	824
2021 Q2	$117K	Buy	887 +17	+2%	+$2.23K	﹤0.01%	878
2021 Q1	$112K	Buy	870 +318	+58%	+$39.2K	0.01%	826
2020 Q4	$66K	Buy	552 +9	+2%	+$1.1K	﹤0.01%	955
2020 Q3	$62K	Buy	543 +14	+3%	+$1.65K	﹤0.01%	881
2020 Q2	$60K	Sell	529 -224	-30%	-$23.8K	﹤0.01%	884
2020 Q1	$60K	Buy	753 +11	+1%	+$1.14K	0.01%	826
2019 Q4	$79K	Buy	742 +28	+4%	+$2.92K	0.01%	801
2019 Q3	$76K	Buy	714 +98	+16%	+$10.1K	0.01%	764
2019 Q2	$63K	Buy	616 +111	+22%	+$10.7K	0.01%	812
2019 Q1	$45K	Buy	505 +216	+75%	+$18.7K	﹤0.01%	914
2018 Q4	$24K	Sell	289 -635	-69%	-$59.5K	﹤0.01%	1081
2018 Q3	$100K	Sell	924 -10	-1%	-$1.1K	0.01%	644
2018 Q2	$103K	Sell	934 -43	-4%	-$4.48K	0.01%	607
2018 Q1	$98K	Buy	+977	New	+$100K	0.01%	542
2016 Q4	–	Sell	-541	Closed	-$46K	–	486
2016 Q3	$46K	Buy	541 +400	+284%	+$33.6K	0.01%	550
2016 Q2	$11K	Sell	141 -1	-0.7%	-$76	﹤0.01%	881
2016 Q1	$10K	Buy	142 +2	+1%	+$134	﹤0.01%	840
2015 Q4	$10K	Buy	140 +118	+536%	+$7.93K	﹤0.01%	725
2015 Q3	$1K	Buy	+22	New	+$1.54K	﹤0.01%	1110
2015 Q1	–	Sell	-86	Closed	-$6K	–	983
2014 Q4	$6K	Hold	86	–	–	﹤0.01%	570
2014 Q3	$5K	Hold	86	–	–	﹤0.01%	536
2014 Q2	$5K	Hold	86	–	–	﹤0.01%	584
2014 Q1	$5K	Hold	86	–	–	﹤0.01%	522
2013 Q4	$5K	Buy	+86	New	+$5.1K	﹤0.01%	517

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

SignatureFD's DGX Position: Q1 2026 in Review

SignatureFD increased its Quest Diagnostics (DGX) stake by 3.7% in Q1 2026, buying an estimated $11.9K and bringing the position to 1,699 shares worth $333K. The position accounts for 0.01% of the portfolio, ranked #764.

SignatureFD first reported a position in DGX in Q4 2013 and has held it in 43 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

SignatureFD held 1,699 shares of Quest Diagnostics worth $333K as of Q1 2026.
SignatureFD bought 61 Quest Diagnostics shares in Q1 2026, an estimated $11.9K.
Quest Diagnostics made up 0.01% of SignatureFD's portfolio in Q1 2026, its #764 holding.
SignatureFD first reported a position in Quest Diagnostics in Q4 2013 and has held it in 43 quarters since.
1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.